Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Clinical trial NCT06845241 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06845241
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2028-07-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.